Web Exclusive

The current economic crisis offers an opportunity to focus on priorities in healthcare in an effort to enact true healthcare reform, said Len Nichols, PhD, healthcare economist and Director of the Health Policy Program at the New America Foundation, during the 2009 annual meeting of the American College of Cardiology (ACC).

Ms Nancy-Ann DeParle, Director of the White House Office of Health Reform and a former administrator with Medicare and Medicaid, says President Obama’s key goals for healthcare reform and the process to get there have a good chance of succeeding. “The goals are to keep the costs low, include private plans, provide a competitive choice for consumers, and include a government plan.”

At the recent 2010 Digestive Disease Week (DDW) meeting, positive data were presented for several investigational drugs close to approval for gastrointestinal (GI) disorders, including hepatitis C virus (HCV), Crohn’s disease, irritable bowel syndrome (IBS), and constipation. 

Several new drugs, currently at advanced stages of development, were featured during the annual meeting of the American College of Cardiology (ACC) in March 2009.

A few drugs in development were featured at the Infectious Diseases Society of America (IDSA) 2009 annual meeting. Infectious disease (ID) experts warn that the ID pipeline is dying, with only few drugs currently in development. Yet, the threat of new infections is growing worldwide in the inpatient and outpatient settings.

Several new classes of drugs in the pipeline to improve glycemic control, including a rapid-acting inhalable insulin using a new technology, were featured at the 2009 annual meeting of the American Diabetes Association (ADA).

Attacking the Kidney’s Sodium Glucose Cotransporter

Inhibitors of sodium glucose cotransporter (SGLT)-2 offer an alternate way to reduce fasting glucose and hemoglobin (Hb) A1c levels, independent of acting on insulin.

Page 7 of 7
Results 61 - 68 of 68
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME